Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo, B. Taylor Thompson, Jennifer G. Wilson, Joseph E. Levitt, Angela J. Rogers, Jeffrey E. Gotts, Jeanine P. Wiener-Kronish, Ednan K. Bajwa, Michael P. Donahoe, Bryan J. McVerry, Luis A. Ortiz, Matthew Exline, John W. Christman, Jason Abbott, Kevin L. Delucchi, Lizette Caballero, Melanie McMillan, David H. McKennaKathleen D. Liu

Research output: Contribution to journalArticlepeer-review

189 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial'. Together they form a unique fingerprint.

Medicine & Life Sciences